The gap between observational studies and randomized controlled trials Subgroup analysis of four randomized controlled trials in a meta-analysis showed a positive association with borderline significance between HRT use and lung cancer (RR = 1.18, 95% CI 0.99-1.42).
← all excerpts
Hormone replacement therapy and lung cancer risk in women: a meta-analysis of cohort studies: Hormone replacement therapy and lung cancer risk.
1
—
—